602 filings
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
9 May 24
Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results
4:11pm
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
19 Mar 24
Submission of Matters to a Vote of Security Holders
4:38pm
8-K/A
ARWR
Arrowhead Pharmaceuticals Inc.
15 Mar 24
Departure of Directors or Certain Officers
7:21pm
S-8
ARWR
Arrowhead Pharmaceuticals Inc.
28 Feb 24
Registration of securities for employees
5:25pm
DEFA14A
0cltg
27 Feb 24
Additional proxy soliciting materials
5:08pm
8-K
tr4eh0vmq cuu3ocmu
21 Feb 24
Departure of Directors or Certain Officers
5:42pm
8-K
pm4meil
6 Feb 24
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
4:07pm
ARS
sztg7ojnt bh
29 Jan 24
Annual report to shareholders
12:00am
DEFA14A
bio54qepjcfajq
26 Jan 24
Additional proxy soliciting materials
5:28pm
8-K
7jq0fzd
22 Jan 24
Departure of Directors or Certain Officers
12:00am
8-K
289abdn59a
4 Jan 24
Entry into a Material Definitive Agreement
5:27pm
424B5
eo7tmt
4 Jan 24
Prospectus supplement for primary offering
5:01pm
8-K
82zwl3z5o68urr
5 Dec 23
Changes in Registrant's Certifying Accountant
5:16pm
8-K
bmms3hue
29 Nov 23
Arrowhead Pharmaceuticals Reports Fiscal 2023 Year End Results
4:10pm
8-K
n2lxz9i6bl1 b1i684b
7 Aug 23
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results
4:10pm